Excessive daytime sleepiness (EDS) is a major symptom of obstructive sleep apnoea (OSA),
defined as the inability to stay awake during the day. Its clinical descriptors remain elusive …

Substantial night-to-night variability in obstructive sleep apnoea (OSA) severity has raised
misdiagnosis and misdirected treatment concerns with the current prevailing single-night …

Rationale: Randomized controlled trials showed no effect of positive airway pressure (PAP)
therapy for obstructive sleep apnea (OSA) on cardiovascular (CV) risk. However, patient …

Background Obstructive sleep apnea (OSA) is common in heart failure with preserved
ejection fraction (HFpEF). However, current evidence is equivocal regarding the potential …

Purpose Insomnia symptoms and sleep apnea frequently co-occur and are associated with
worse sleep, daytime function, mental health and quality of life, compared to either insomnia …

Background Obstructive sleep apnea (OSA) is a common comorbidity in patients with heart
failure, although current evidence is equivocal regarding the potential benefits of treating …

Obstructive sleep apnea (OSA) is one of the most common and serious sleep‐related
breathing disorders with a high prevalence among patients with cardiovascular (CV) …

Continuous positive airway pressure (CPAP) is the first-line treatment for obstructive sleep
apnea (OSA). Although CPAP improves symptoms (eg, daytime sleepiness), there is a lack …

Study Objectives: There is a complex interplay between obstructive sleep apnea (OSA) and
type 2 diabetes. There are minimal data regarding the effects of treating OSA with positive …

Background Obstructive sleep apnea (OSA) is one of the leading respiratory disorders,
increasing the risk of cardiometabolic diseases. In the study, we investigated the association …